Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Lymphoid 1

Conditions

Breast Neoplasms 8Prostatic Neoplasms 7Colorectal Neoplasms 4Colorectal Neoplasms, Hereditary Nonpolyposis 3Rectal Neoplasms 2Ovarian Neoplasms 2Neoplastic Syndromes, Hereditary 2Colonic Neoplasms 2Carcinoma, Intraductal, Noninfiltrating 2Tuberous Sclerosis 1Thyroid Neoplasms 1Sarcoma 1Pyloric Stenosis, Hypertrophic 1Primary Ovarian Insufficiency 1Polycystic Ovary Syndrome 1Pheochromocytoma 1Pediatric Solid Tumor 1Paraganglioma 1Pancreatic Neoplasms 1Pancreatic Ductal Adenocarcinoma 1Neoplasms, Unknown Primary 1Neoplasms 1Neoplasm Metastasis 1Multiple Myeloma 1Melanoma 1Lymphoproliferative Disorders 1Lymphangioleiomyomatosis 1Lipodystrophy, Familial Partial 1Kidney Neoplasms 1Histiocytosis, Non-Langerhans-Cell 1

Interventions

Dexamethasone 239Lenalidomide 145daratumumab 123Bortezomib 101pomalidomide 86Calcium Dobesilate 76carfilzomib 74Cyclophosphamide 70Specimen Handling 42isatuximab 40Biopsy 40fludarabine 36belantamab mafodotin 36Magnetic Resonance Spectroscopy 35talquetamab 29dexamethasone acetate 27dexamethasone 21-phosphate 27Melphalan 27auricularum 26iberdomide 25ixazomib 22fludarabine phosphate 22selinexor 21elotuzumab 21Whole-Body Irradiation 14X-Rays 13tocilizumab 12venetoclax 11Mycophenolic Acid 10trametinib 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Multiple Myeloma × Genetic Testing × 1 year × Clear all
NCT06630104 2026-01-08

Understanding the Mechanisms of Clonal and Non-clonal Cytopenia Following CAR-T Therapy for Multiple Myeloma or CD19+ Lymphoproliferative Disorder (LPD)

Mayo Clinic

Phase NA Recruiting
82 enrolled
LymphoidPlasma cell

Lymphoproliferative Disorders, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡